Literature DB >> 8495979

Expression of the identical V beta gene in human T-cell clones does not confer the same pattern of responsiveness to bacterial enterotoxins.

S Quaratino1, A Verhoef, M Kahan, M Londei.   

Abstract

Superantigens are the most potent T-cell mitogens so far described, and are believed to activate virtually all the T lymphocytes bearing the appropriate V beta segment in their T-cell receptor (TcR). In order to determine whether the expression of the identical V beta gene confers the same pattern of responsiveness to bacterial superantigens, we have established a panel of 20 untransformed human T-cell clones expressing the V beta 6.7a gene in their TcR. The V beta usage was defined by immunostaining, using the V beta 6.7a-specific monoclonal antibody (mAb) OT145, and confirmed by DNA sequencing of the beta-chain. Although all the clones analysed expressed the same V beta gene, they had disparate patterns of proliferation to challenge with a panel of bacterial enterotoxins. This study demonstrates that the mere expression of the same V beta region by T lymphocytes does not grant an indistinguishable responsiveness to bacterial superantigens. Thus other, as yet undefined, T-lymphocyte components play a key role in the process of T-cell activation induced by bacterial superantigens, influencing the effects mediated by exogenous superantigens on human T cells.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8495979      PMCID: PMC1421899     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  26 in total

1.  Class II MHC molecules are specific receptors for staphylococcus enterotoxin A.

Authors:  J A Mollick; R G Cook; R R Rich
Journal:  Science       Date:  1989-05-19       Impact factor: 47.728

2.  Definition of a population of CD4-8- T cells that express the alpha beta T-cell receptor and respond to interleukins 2, 3, and 4.

Authors:  M Londei; A Verhoef; P De Berardinis; M Kissonerghis; B Grubeck-Loebenstein; M Feldmann
Journal:  Proc Natl Acad Sci U S A       Date:  1989-11       Impact factor: 11.205

3.  Persistence of collagen type II-specific T-cell clones in the synovial membrane of a patient with rheumatoid arthritis.

Authors:  M Londei; C M Savill; A Verhoef; F Brennan; Z A Leech; V Duance; R N Maini; M Feldmann
Journal:  Proc Natl Acad Sci U S A       Date:  1989-01       Impact factor: 11.205

Review 4.  Self-tolerance eliminates T cells specific for Mls-modified products of the major histocompatibility complex.

Authors:  J W Kappler; U Staerz; J White; P C Marrack
Journal:  Nature       Date:  1988-03-03       Impact factor: 49.962

5.  Human T-cell clones from autoimmune thyroid glands: specific recognition of autologous thyroid cells.

Authors:  M Londei; G F Bottazzo; M Feldmann
Journal:  Science       Date:  1985-04-05       Impact factor: 47.728

6.  V beta-specific stimulation of human T cells by staphylococcal toxins.

Authors:  J Kappler; B Kotzin; L Herron; E W Gelfand; R D Bigler; A Boylston; S Carrel; D N Posnett; Y Choi; P Marrack
Journal:  Science       Date:  1989-05-19       Impact factor: 47.728

7.  The V beta-specific superantigen staphylococcal enterotoxin B: stimulation of mature T cells and clonal deletion in neonatal mice.

Authors:  J White; A Herman; A M Pullen; R Kubo; J W Kappler; P Marrack
Journal:  Cell       Date:  1989-01-13       Impact factor: 41.582

8.  Clonal anergy induced in mature V beta 6+ T lymphocytes on immunizing Mls-1b mice with Mls-1a expressing cells.

Authors:  H G Rammensee; R Kroschewski; B Frangoulis
Journal:  Nature       Date:  1989-06-15       Impact factor: 49.962

9.  Influence of T cell receptor V alpha expression on Mlsa superantigen-specific T cell responses.

Authors:  M S Vacchio; O Kanagawa; K Tomonari; R J Hodes
Journal:  J Exp Med       Date:  1992-05-01       Impact factor: 14.307

10.  T cell stimulation by staphylococcal enterotoxins. Clonally variable response and requirement for major histocompatibility complex class II molecules on accessory or target cells.

Authors:  B Fleischer; H Schrezenmeier
Journal:  J Exp Med       Date:  1988-05-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.